Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation

Anesthesia and Analgesia

Volumn 109, Issue 2, 2009, Pages 412-417

  Qi, Feng ^a   Ogawa, Koji ^a   Tokinaga, Yasuyuki ^a   Uematsu, Nobuhiko ^a   Minonishi, Toshiyuki ^a   Hatano, Yoshio ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ISOFLURANE; MYOSIN; MYOSIN LIGHT CHAIN PHOSPHATASE; PROTEIN CPI 17; PROTEIN MYPT1; SEVOFLURANE; UNCLASSIFIED DRUG; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; MUSCLE PROTEIN; MYOSIN LIGHT CHAIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 1; PPP1R12A PROTEIN, RAT; PPP1R14A PROTEIN, RAT; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FORCE TRANSDUCER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SMOOTH MUSCLE CONTRACTION; VASOCONSTRICTION; WESTERN BLOTTING; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; IN VITRO STUDY; KINETICS; METABOLISM; MUSCLE ISOMETRIC CONTRACTION; PHOSPHORYLATION; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANESTHETICS, INHALATION; ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; ISOFLURANE; ISOMETRIC CONTRACTION; KINETICS; MALE; METHYL ETHERS; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOSIN LIGHT CHAINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; RATS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 67849104738     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181ac6d96     Document Type: Article

References (21)

1. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000;52:639-672
2. 2+ sensitization of the contractile apparatus in vascular smooth muscle. J Pharmacol Sci 2007;104:109-115
3. 2+ sensitivity in vascular smooth muscle. J Smooth Muscle Res 2004;40:219-236
4. 2+ sensitization of contraction in arterial smooth muscle. Circ Res 2007;100:121-129
5. 2+ sensitivity of smooth muscle and non-muscle myosin II: modulated by G proteins, kinases and myosin phosphatase. Physiol Rev 2003;83:1325-1358
6. Ito M, Nakano T, Erdodi F, Hartshorne DJ. Myosin phosphatase: structure, regulation and function. Mol Cell Biochem 2004;259: 197-209
7. 2+ sensitization in rabbit smooth muscle. J Physiol 2003;546:879-889
8. Hartshorne DJ, Ito M, Erdodi F. Role of protein phosphatase type 1 in contractile functions: myosin phosphatase. J Biol Chem 2004;279:37211-37214
9. Eto M, Kitazawa T, Yazawa M, Mukai H, Ono Y, Brautigan DL. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. J Biol Chem 2001;276:29072-29078
10. Trinkle-Mulcahy L, Ichikawa K, Hartshorne DJ, Siegman MJ, Butler TM. Thiophosphorylation of the 130-kDa subunit is associated with a decreased activity of myosin light chain phosphatase in α-toxin-permeabilized smooth muscle. J Biol Chem 1995;270:18191-18194
11. Woodsome TP, Polzin A, Kitazawa K, Eto M, Kitazawa T. Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells. J Cell Sci 2006;119:1769-1780
12. Yu J, Ogawa K, Tokinaga Y, Hatano Y. Sevoflurane inhibits guanosine 5'-[γ-thio] triphosphate-stimulated, Rho/Rho kinasemediated contraction of rat aortic smooth muscle. Anesthesiology 2003;99:645-651
13. 2+- elicited contraction of rat aortic smooth muscle. Anesthesiology 2004;100:879-884
14. Ishikawa A, Ogawa K, Tokinaga Y, Uematsu N, Mizumoto K, Hatano Y. The mechanism behind the inhibitory effect of isoflurane on angiotensin II induced vascular contraction is different from that of sevoflurane. Anesth Analg 2007;105:97-102
15. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85
16. Park KW, Dai HB, Lowenstein E, Sellke FW. Protein kinase C-induced contraction is inhibited by halothane but enhanced by isoflurane in rat coronary arteries. Anesth Analg 1996;83:286-290 (Pubitemid 26255819)
17. David JS, Tavernier B, Amour J, Vivien B, Coriat P, Riou B. Myocardial effect effects of halothane and sevoflurane in diabetic rats. Anesthesiology 2004;100:1179-1187
18. 2+ sensitivity in the bovine middle cerebral artery. Br J Pharmacol 2003;140:871-880
19. Bi D, Nishimura J, Niiro N, Hirano K, Kanaide H. Contractile properties of the cultured vascular smooth muscle cells: the crucial role played by RhoA in the regulation of contractility. Circ Res 2005;96:890-897
20. Karaki H, Ozaki H, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ, Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 1997;49:157-230
21. Hagerty L, Weitzel DH, Chambers J, Fortner CN, Brush MH, Loiselle D, Hosoya H, Haystead TAJ. Rock1 phosphorylates and activates zipper-interacting protein kinase. J Biol Chem 2007;282:4884-4893